Shares of Agilon Health, Inc. (NYSE:AGL – Get Free Report) have received a consensus rating of “Hold” from the eighteen research firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $4.0714.
AGL has been the subject of a number of recent analyst reports. Evercore ISI lowered their price target on Agilon Health from $5.00 to $3.00 and set an “in-line” rating for the company in a research report on Wednesday, July 9th. Cowen reissued a “hold” rating on shares of Agilon Health in a research note on Tuesday, April 15th. Benchmark cut their price objective on Agilon Health from $4.00 to $1.50 and set a “buy” rating on the stock in a research report on Wednesday. TD Cowen increased their target price on Agilon Health from $3.50 to $6.00 and gave the stock a “hold” rating in a research report on Tuesday, April 15th. Finally, Robert W. Baird lowered their target price on Agilon Health from $6.00 to $5.00 and set a “neutral” rating for the company in a research note on Tuesday, April 15th.
Get Our Latest Research Report on AGL
Agilon Health Stock Up 1.4%
Agilon Health (NYSE:AGL – Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.14). The company had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%. Agilon Health’s revenue for the quarter was down 5.9% on a year-over-year basis. During the same period last year, the firm earned ($0.07) earnings per share. As a group, equities analysts expect that Agilon Health will post -0.59 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Agilon Health
Several institutional investors and hedge funds have recently made changes to their positions in AGL. SG Americas Securities LLC boosted its stake in Agilon Health by 1,271.3% during the 1st quarter. SG Americas Securities LLC now owns 144,189 shares of the company’s stock valued at $624,000 after purchasing an additional 133,674 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Agilon Health by 21.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company’s stock valued at $432,000 after purchasing an additional 17,866 shares during the last quarter. Nisa Investment Advisors LLC grew its position in Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock worth $41,000 after purchasing an additional 6,783 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Agilon Health by 41.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company’s stock valued at $644,000 after buying an additional 98,377 shares during the last quarter. Finally, Cerity Partners LLC bought a new position in shares of Agilon Health during the 4th quarter valued at $34,000.
Agilon Health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
- Five stocks we like better than Agilon Health
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- RSI Stock Soars 22% On Q2 Blowout—Will PENN Match the Momentum?
- Dividend Capture Strategy: What You Need to Know
- How DigitalOcean’s Focus Is Fueling Explosive Growth
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Can Celsius Stock Keep Its Momentum Going Any Longer?
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.